Optometry Times On the Air

Live from Vision Expo West 2021

Marc Bloomenstein, OD, FAAO, and Editorial Advisory Board member for Optometry Times® outlines what attendees can anticipate from the greatest anterior segment disease and medical management of contact lens complications course ever at Vision Expo West.

Kerry Gelb, OD, talks with Gretchyn Bailey, NCLC, FAAO, about what’s coming with “Open Your Eyes.” Take a look!

Colette Carlson, professional speaker and human behavior expert, says that relationships can be transformed through the power of connected conversations. She recommends that ODs rely on stories, not data, to build trust in order to influence patients. Plus, staying “in the now” with each patient helps to keep ODs focused on the patient in front of them. Check out her conversation with Optometry Times® Editor in Chief Gretchyn M. Bailey, NCLC, FAAO.

Benjamin Gaddie, OD, FAAO, cochair of Vision Expo Meetings, outlines what attendees can anticipate about Vision Expo East 2021 in Orlando.

Alcon recently launched a multi-dose version of preservative-free lubrication drop Systane called Systane Hydration Multi-Dose Preservative-Free. Sean Clark, general manager of U.S. vision care at Alcon talks about it with Optometry Times® Editor in Chief Gretchyn M. Bailey, NCLC, FAAO.

Jimmie Johnson, 7-time NASCAR cup winner and IndyCar rookie, talks with Optometry Times® Editor in Chief Gretchyn Bailey, NCLC, FAAO, about how ocular allergies affect his driving and day-to-day life.

Johnson discusses his history of ocular allergies and what is coming next for him. Plus, he mentions his daughter’s allergies and how Alcon Pataday Once Daily Relief (olopatadine hydrochloride 0.2%) helped both of them.

Andy Pawson, president and general manager of Alcon global vision care, talks with Optometry Times® Editor in Chief Gretchyn Bailey about the company’s plan to launch a new contact lens in early 2022—Total 30 is a monthly lens incorporating water-gradient technology. Pawson discusses plans for line extensions of Total 30 to toric and multifocal lenses and comments on the status of Precision 1 for Astigmatism, which launched in late 2020.

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.

Play Video

Rhett Schiffman, MD, MD, MHSA, chief medical officer and head of research and development at Visus Therapeutics, talks with Gretchyn Bailey, NCLC, FAAO, editor in chief of Optometry Times® about Brimichol, the company’s presbyopia-correcting eyedrop that recently received FDA acceptance of its investigational new drug (IND) application.